Crossmark

A prospective randomized multicenter phase I/II clinical trial to evaluate safety and efficacy of NOVOCART disk plus autologous disk chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disks to avoid secondary disease: safety results of Phase I—a short report

Crossref DOI link: https://doi.org/10.1007/s10143-016-0781-0

Published Online: 2016-08-27

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tschugg, Anja

Diepers, Michael

Simone, Steinert

Michnacs, Felix

Quirbach, Sebastian

Strowitzki, Martin

Meisel, Hans Jörg

Thomé, Claudius
Funding

Funding for this research was provided by:

University of Innsbruck and Medical University of Innsbruck
License Information

License valid from 2016-08-27

Updates are available Correction dated 2016-10-08

Click to view Correction: https://doi.org/10.1007/s10143-016-0787-7